Європейський Союз - англійська - EMA (European Medicines Agency)

actavis group ptc ehf   - pioglitazone hydrochloride - diabetes mellitus, type 2 - drugs used in diabetes - pioglitazone is indicated as second or third line treatment of type 2 diabetes mellitus as described below:as monotherapyin adult patients (particularly overweight patients) inadequately controlled by diet and exercise for whom metformin is inappropriate because of contraindications or intolerance.as dual oral therapy in combination withmetformin, in adult patients (particularly overweight patients) with insufficient glycaemic control despite maximal tolerated dose of monotherapy with metformin.a sulphonylurea, only in adult patients who show intolerance to metformin or for whom metformin is contraindicated, with insufficient glycaemic control despite maximal tolerated dose of monotherapy with a sulphonylurea.as triple oral therapy in combination withmetformin and a sulphonylurea, in adult patients (particularly overweight patients) with insufficient glycaemic control despite dual oral therapy.pioglitazone is also indicated for combination with insulin in type 2 diabetes mellitus adult patients with insufficient glycaemic control on insulin for whom metformin is inappropriate because of contraindications or intolerance (see section 4.4).after initiation of therapy with pioglitazone, patients should be reviewed after 3 to 6 months to assess adequacy of response to treatment (e.g. reduction in hba1c). in patients who fail to show an adequate response, pioglitazone should be discontinued. in light of potential risks with prolonged therapy, prescribers should confirm at subsequent routine reviews that the benefit of pioglitazone is maintained (see section 4.4).

Європейський Союз - англійська - EMA (European Medicines Agency)

actavis group ptc ehf - rivastigmine hydrogen tartrate - dementia; alzheimer disease; parkinson disease - psychoanaleptics, - symptomatic treatment of mild to moderately severe alzheimer's dementia.symptomatic treatment of mild to moderately severe dementia in patients with idiopathic parkinson's disease.

Європейський Союз - англійська - EMA (European Medicines Agency)

actavis group ptc ehf - telmisartan - hypertension - agents acting on the renin-angiotensin system - hypertensiontreatment of essential hypertension in adults.cardiovascular preventionreduction of cardiovascular morbidity in patients with:manifest atherothrombotic cardiovascular disease (history of coronary heart disease, stroke, or peripheral arterial disease) or;type 2 diabetes mellitus with documented target organ damage.

Європейський Союз - англійська - EMA (European Medicines Agency)

actavis group ptc ehf   - zoledronic acid monohydrate - fractures, bone - drugs for treatment of bone diseases - prevention of skeletal-related events (pathological fractures, spinal compression, radiation or surgery to bone, or tumour-induced hypercalcaemia) in adult patients with advanced malignancies involving bone.treatment of adult patients with tumour-induced hypercalcaemia.

Мальта - англійська - Malta Medicines Authority

actavis group ptc ehf - granisetron hydrochloride - coated tablet - granisetron hydrochloride 1.12 mg - antiemetics and antinauseants

Мальта - англійська - Malta Medicines Authority

actavis group ptc ehf - granisetron hydrochloride - coated tablet - granisetron hydrochloride 2.24 mg - antiemetics and antinauseants

Ірландія - англійська - HPRA (Health Products Regulatory Authority)

actavis group hf - ibuprofen - film-coated tablet - 600 milligram(s) - propionic acid derivatives; ibuprofen

Ірландія - англійська - HPRA (Health Products Regulatory Authority)

actavis group hf - disulfiram - effervescent tablet - 400 milligram(s) - drugs used in alcohol dependence; disulfiram

Ірландія - англійська - HPRA (Health Products Regulatory Authority)

actavis group ptc ehf - atenolol - film coated tablet - 50 milligram - beta blocking agents, selective

Ірландія - англійська - HPRA (Health Products Regulatory Authority)

actavis group ptc ehf - atenolol - film coated tablet - 25 milligram - beta blocking agents, selective